 | • レポートコード：QAF27752 • 出版社/出版日：QYResearch / 2021年3月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の鉄キレート化剤市場について種類別（デフェロキサミン、デフェリプロン、デフェラシロクス）、用途別（輸血性鉄過剰症、NTDT起因性鉄過剰症）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・鉄キレート化剤市場の概要 ・世界の主要地域別鉄キレート化剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の鉄キレート化剤市場規模2016-2021：種類別（デフェロキサミン、デフェリプロン、デフェラシロクス） ・世界の鉄キレート化剤市場予測2012-2027：種類別（デフェロキサミン、デフェリプロン、デフェラシロクス） ・世界の鉄キレート化剤市場規模2016-2021：用途別（輸血性鉄過剰症、NTDT起因性鉄過剰症） ・世界の鉄キレート化剤市場予測2012-2027：用途別（輸血性鉄過剰症、NTDT起因性鉄過剰症） ・鉄キレート化剤のアメリカ市場規模と予測2016-2021 ・鉄キレート化剤のヨーロッパ市場規模と予測2016-2021 ・鉄キレート化剤の中国市場規模と予測2016-2021 ・鉄キレート化剤の日本市場規模と予測2016-2021 ・鉄キレート化剤の東南アジア市場規模と予測2016-2021 ・鉄キレート化剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Apotex Inc. (Canada)、Cipla (India)、Novartis (Switzerland)、Sun Pharma (India)、Natco Pharma (India)） ・鉄キレート化剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・鉄キレート化剤の市場動向・機会・課題 ・調査の結論 |
This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
North America is the largest consumption region of Iron Chelation Drug, with a consumption value market share nearly 31.03% in 2016. Europe is the second largest consumption region of Iron Chelation Drug, enjoying consumption value market share nearly 25.30% in 2016. Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Iron Chelation Drug Market
The global Iron Chelation Drug market was valued at US$ 4983.2 in 2020 and will reach US$ 6489.5 million by the end of 2027, growing at a CAGR of 4.5% during 2022-2027.
Global Iron Chelation Drug Scope and Market Size
The global Iron Chelation Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Iron Chelation Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Deferoxamine
Deferiprone
Deferasirox
Segment by Application
Transfusional Iron Overload
NTDT Caused Iron Overload
The Iron Chelation Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Iron Chelation Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Apotex Inc. (Canada)
Cipla (India)
Novartis (Switzerland)
Sun Pharma (India)
Natco Pharma (India)
1 Iron Chelation Drug Market Overview
1.1 Iron Chelation Drug Product Scope
1.2 Iron Chelation Drug Segment by Type
1.2.1 Global Iron Chelation Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Deferoxamine
1.2.3 Deferiprone
1.2.4 Deferasirox
1.3 Iron Chelation Drug Segment by Application
1.3.1 Global Iron Chelation Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Transfusional Iron Overload
1.3.3 NTDT Caused Iron Overload
1.4 Iron Chelation Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Iron Chelation Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Iron Chelation Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Iron Chelation Drug Price Trends (2016-2027)
2 Iron Chelation Drug Estimates and Forecasts by Region
2.1 Global Iron Chelation Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Iron Chelation Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Iron Chelation Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Iron Chelation Drug Revenue Market Share by Region (2016-2021)
2.3 Global Iron Chelation Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Iron Chelation Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Iron Chelation Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Iron Chelation Drug Estimates and Projections (2016-2027)
2.4.2 Europe Iron Chelation Drug Estimates and Projections (2016-2027)
2.4.3 China Iron Chelation Drug Estimates and Projections (2016-2027)
2.4.4 Japan Iron Chelation Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Iron Chelation Drug Estimates and Projections (2016-2027)
2.4.6 India Iron Chelation Drug Estimates and Projections (2016-2027)
3 Global Iron Chelation Drug Competition Landscape by Players
3.1 Global Top Iron Chelation Drug Players by Sales (2016-2021)
3.2 Global Top Iron Chelation Drug Players by Revenue (2016-2021)
3.3 Global Iron Chelation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Iron Chelation Drug as of 2020)
3.4 Global Iron Chelation Drug Average Price by Company (2016-2021)
3.5 Manufacturers Iron Chelation Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Iron Chelation Drug Market Size by Type
4.1 Global Iron Chelation Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Iron Chelation Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Iron Chelation Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Iron Chelation Drug Price by Type (2016-2021)
4.2 Global Iron Chelation Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Iron Chelation Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Iron Chelation Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Iron Chelation Drug Price Forecast by Type (2022-2027)
5 Global Iron Chelation Drug Market Size by Application
5.1 Global Iron Chelation Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Iron Chelation Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Iron Chelation Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Iron Chelation Drug Price by Application (2016-2021)
5.2 Global Iron Chelation Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Iron Chelation Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Iron Chelation Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Iron Chelation Drug Price Forecast by Application (2022-2027)
6 North America Iron Chelation Drug Market Facts & Figures
6.1 North America Iron Chelation Drug Sales by Company
6.1.1 North America Iron Chelation Drug Sales by Company (2016-2021)
6.1.2 North America Iron Chelation Drug Revenue by Company (2016-2021)
6.2 North America Iron Chelation Drug Sales Breakdown by Type
6.2.1 North America Iron Chelation Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Iron Chelation Drug Sales Breakdown by Type (2022-2027)
6.3 North America Iron Chelation Drug Sales Breakdown by Application
6.3.1 North America Iron Chelation Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Iron Chelation Drug Sales Breakdown by Application (2022-2027)
7 Europe Iron Chelation Drug Market Facts & Figures
7.1 Europe Iron Chelation Drug Sales by Company
7.1.1 Europe Iron Chelation Drug Sales by Company (2016-2021)
7.1.2 Europe Iron Chelation Drug Revenue by Company (2016-2021)
7.2 Europe Iron Chelation Drug Sales Breakdown by Type
7.2.1 Europe Iron Chelation Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Iron Chelation Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Iron Chelation Drug Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)
8 China Iron Chelation Drug Market Facts & Figures
8.1 China Iron Chelation Drug Sales by Company
8.1.1 China Iron Chelation Drug Sales by Company (2016-2021)
8.1.2 China Iron Chelation Drug Revenue by Company (2016-2021)
8.2 China Iron Chelation Drug Sales Breakdown by Type
8.2.1 China Iron Chelation Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Iron Chelation Drug Sales Breakdown by Type (2022-2027)
8.3 China Iron Chelation Drug Sales Breakdown by Application
8.3.1 China 248 Sales Breakdown by Application (2016-2021)
8.3.2 China 248 Sales Breakdown by Application (2022-2027)
9 Japan Iron Chelation Drug Market Facts & Figures
9.1 Japan Iron Chelation Drug Sales by Company
9.1.1 Japan Iron Chelation Drug Sales by Company (2016-2021)
9.1.2 Japan Iron Chelation Drug Revenue by Company (2016-2021)
9.2 Japan Iron Chelation Drug Sales Breakdown by Type
9.2.1 Japan Iron Chelation Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Iron Chelation Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Iron Chelation Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Iron Chelation Drug Market Facts & Figures
10.1 Southeast Asia Iron Chelation Drug Sales by Company
10.1.1 Southeast Asia Iron Chelation Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Iron Chelation Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Iron Chelation Drug Sales Breakdown by Type
10.2.1 Southeast Asia Iron Chelation Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Iron Chelation Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Iron Chelation Drug Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Iron Chelation Drug Market Facts & Figures
11.1 India Iron Chelation Drug Sales by Company
11.1.1 India Iron Chelation Drug Sales by Company (2016-2021)
11.1.2 India Iron Chelation Drug Revenue by Company (2016-2021)
11.2 India Iron Chelation Drug Sales Breakdown by Type
11.2.1 India Iron Chelation Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Iron Chelation Drug Sales Breakdown by Type (2022-2027)
11.3 India Iron Chelation Drug Sales Breakdown by Application
11.3.1 India Iron Chelation Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Iron Chelation Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Iron Chelation Drug Business
12.1 Apotex Inc. (Canada)
12.1.1 Apotex Inc. (Canada) Corporation Information
12.1.2 Apotex Inc. (Canada) Business Overview
12.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Apotex Inc. (Canada) Iron Chelation Drug Products Offered
12.1.5 Apotex Inc. (Canada) Recent Development
12.2 Cipla (India)
12.2.1 Cipla (India) Corporation Information
12.2.2 Cipla (India) Business Overview
12.2.3 Cipla (India) Iron Chelation Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cipla (India) Iron Chelation Drug Products Offered
12.2.5 Cipla (India) Recent Development
12.3 Novartis (Switzerland)
12.3.1 Novartis (Switzerland) Corporation Information
12.3.2 Novartis (Switzerland) Business Overview
12.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis (Switzerland) Iron Chelation Drug Products Offered
12.3.5 Novartis (Switzerland) Recent Development
12.4 Sun Pharma (India)
12.4.1 Sun Pharma (India) Corporation Information
12.4.2 Sun Pharma (India) Business Overview
12.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharma (India) Iron Chelation Drug Products Offered
12.4.5 Sun Pharma (India) Recent Development
12.5 Natco Pharma (India)
12.5.1 Natco Pharma (India) Corporation Information
12.5.2 Natco Pharma (India) Business Overview
12.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Natco Pharma (India) Iron Chelation Drug Products Offered
12.5.5 Natco Pharma (India) Recent Development
…
13 Iron Chelation Drug Manufacturing Cost Analysis
13.1 Iron Chelation Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Iron Chelation Drug
13.4 Iron Chelation Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Iron Chelation Drug Distributors List
14.3 Iron Chelation Drug Customers
15 Market Dynamics
15.1 Iron Chelation Drug Market Trends
15.2 Iron Chelation Drug Drivers
15.3 Iron Chelation Drug Market Challenges
15.4 Iron Chelation Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Iron Chelation Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Iron Chelation Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Iron Chelation Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Iron Chelation Drug Sales (Kg) by Region (2016-2021)
Table 5. Global Iron Chelation Drug Sales Market Share by Region (2016-2021)
Table 6. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Iron Chelation Drug Revenue Share by Region (2016-2021)
Table 8. Global Iron Chelation Drug Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Iron Chelation Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Iron Chelation Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Iron Chelation Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Iron Chelation Drug Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Iron Chelation Drug Sales Share by Company (2016-2021)
Table 14. Global Iron Chelation Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Iron Chelation Drug Revenue Share by Company (2016-2021)
Table 16. Global Iron Chelation Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Chelation Drug as of 2020)
Table 17. Global Iron Chelation Drug Average Price (USD/g) of Key Company (2016-2021)
Table 18. Manufacturers Iron Chelation Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Iron Chelation Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Iron Chelation Drug Sales (Kg) by Type (2016-2021)
Table 22. Global Iron Chelation Drug Sales Share by Type (2016-2021)
Table 23. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Iron Chelation Drug Price (USD/g) by Type (2016-2021)
Table 25. Global Iron Chelation Drug Sales Share by Type (2022-2027)
Table 26. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Iron Chelation Drug Revenue Share by Type (2022-2027)
Table 28. Global Iron Chelation Drug Price (USD/g) by Type (2022-2027)
Table 29. Global Iron Chelation Drug Sales (Kg) by Application (2016-2021)
Table 30. Global Iron Chelation Drug Sales Share by Application (2016-2021)
Table 31. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Iron Chelation Drug Price (USD/g) by Application (2016-2021)
Table 33. Global Iron Chelation Drug Sales (Kg) by Application (2022-2027)
Table 34. Global Iron Chelation Drug Sales Share by Application (2022-2027)
Table 35. Global Iron Chelation Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Iron Chelation Drug Revenue Share by Application (2022-2027)
Table 37. Global Iron Chelation Drug Price (USD/g) by Application (2022-2027)
Table 38. North America Iron Chelation Drug Sales (Kg) by Company (2016-2021)
Table 39. North America Iron Chelation Drug Sales Market Share by Company (2016-2021)
Table 40. North America Iron Chelation Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Iron Chelation Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Iron Chelation Drug Sales by Type (2016-2021) & (Kg)
Table 43. North America Iron Chelation Drug Sales Market Share by Type (2016-2021)
Table 44. North America Iron Chelation Drug Sales by Type (2022-2027) & (Kg)
Table 45. North America Iron Chelation Drug Sales Market Share by Type (2022-2027)
Table 46. North America Iron Chelation Drug Sales by Application (2016-2021) & (Kg)
Table 47. North America Iron Chelation Drug Sales Market Share by Application (2016-2021)
Table 48. North America Iron Chelation Drug Sales by Application (2022-2027) & (Kg)
Table 49. North America Iron Chelation Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Iron Chelation Drug Sales (Kg) by Company (2016-2021)
Table 51. Europe Iron Chelation Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Iron Chelation Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Iron Chelation Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Iron Chelation Drug Sales by Type (2016-2021) & (Kg)
Table 55. Europe Iron Chelation Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Iron Chelation Drug Sales by Type (2022-2027) & (Kg)
Table 57. Europe Iron Chelation Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Iron Chelation Drug Sales by Application (2016-2021) & (Kg)
Table 59. Europe Iron Chelation Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Iron Chelation Drug Sales by Application (2022-2027) & (Kg)
Table 61. Europe Iron Chelation Drug Sales Market Share by Application (2022-2027)
Table 62. China Iron Chelation Drug Sales (Kg) by Company (2016-2021)
Table 63. China Iron Chelation Drug Sales Market Share by Company (2016-2021)
Table 64. China Iron Chelation Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Iron Chelation Drug Revenue Market Share by Company (2016-2021)
Table 66. China Iron Chelation Drug Sales by Type (2016-2021) & (Kg)
Table 67. China Iron Chelation Drug Sales Market Share by Type (2016-2021)
Table 68. China Iron Chelation Drug Sales by Type (2022-2027) & (Kg)
Table 69. China Iron Chelation Drug Sales Market Share by Type (2022-2027)
Table 70. China Iron Chelation Drug Sales by Application (2016-2021) & (Kg)
Table 71. China Iron Chelation Drug Sales Market Share by Application (2016-2021)
Table 72. China Iron Chelation Drug Sales by Application (2022-2027) & (Kg)
Table 73. China Iron Chelation Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Iron Chelation Drug Sales (Kg) by Company (2016-2021)
Table 75. Japan Iron Chelation Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Iron Chelation Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Iron Chelation Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Iron Chelation Drug Sales by Type (2016-2021) & (Kg)
Table 79. Japan Iron Chelation Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Iron Chelation Drug Sales by Type (2022-2027) & (Kg)
Table 81. Japan Iron Chelation Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Iron Chelation Drug Sales by Application (2016-2021) & (Kg)
Table 83. Japan Iron Chelation Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Iron Chelation Drug Sales by Application (2022-2027) & (Kg)
Table 85. Japan Iron Chelation Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Iron Chelation Drug Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Iron Chelation Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Iron Chelation Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Iron Chelation Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Iron Chelation Drug Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Iron Chelation Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Iron Chelation Drug Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Iron Chelation Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Iron Chelation Drug Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Iron Chelation Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Iron Chelation Drug Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Iron Chelation Drug Sales Market Share by Application (2022-2027)
Table 98. India Iron Chelation Drug Sales (Kg) by Company (2016-2021)
Table 99. India Iron Chelation Drug Sales Market Share by Company (2016-2021)
Table 100. India Iron Chelation Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Iron Chelation Drug Revenue Market Share by Company (2016-2021)
Table 102. India Iron Chelation Drug Sales by Type (2016-2021) & (Kg)
Table 103. India Iron Chelation Drug Sales Market Share by Type (2016-2021)
Table 104. India Iron Chelation Drug Sales by Type (2022-2027) & (Kg)
Table 105. India Iron Chelation Drug Sales Market Share by Type (2022-2027)
Table 106. India Iron Chelation Drug Sales by Application (2016-2021) & (Kg)
Table 107. India Iron Chelation Drug Sales Market Share by Application (2016-2021)
Table 108. India Iron Chelation Drug Sales by Application (2022-2027) & (Kg)
Table 109. India Iron Chelation Drug Sales Market Share by Application (2022-2027)
Table 110. Apotex Inc. (Canada) Corporation Information
Table 111. Apotex Inc. (Canada) Description and Business Overview
Table 112. Apotex Inc. (Canada) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 113. Apotex Inc. (Canada) Iron Chelation Drug Product
Table 114. Apotex Inc. (Canada) Recent Development
Table 115. Cipla (India) Corporation Information
Table 116. Cipla (India) Description and Business Overview
Table 117. Cipla (India) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 118. Cipla (India) Iron Chelation Drug Product
Table 119. Cipla (India) Recent Development
Table 120. Novartis (Switzerland) Corporation Information
Table 121. Novartis (Switzerland) Description and Business Overview
Table 122. Novartis (Switzerland) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 123. Novartis (Switzerland) Iron Chelation Drug Product
Table 124. Novartis (Switzerland) Recent Development
Table 125. Sun Pharma (India) Corporation Information
Table 126. Sun Pharma (India) Description and Business Overview
Table 127. Sun Pharma (India) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 128. Sun Pharma (India) Iron Chelation Drug Product
Table 129. Sun Pharma (India) Recent Development
Table 130. Natco Pharma (India) Corporation Information
Table 131. Natco Pharma (India) Description and Business Overview
Table 132. Natco Pharma (India) Iron Chelation Drug Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 133. Natco Pharma (India) Iron Chelation Drug Product
Table 134. Natco Pharma (India) Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Iron Chelation Drug Distributors List
Table 138. Iron Chelation Drug Customers List
Table 139. Iron Chelation Drug Market Trends
Table 140. Iron Chelation Drug Market Drivers
Table 141. Iron Chelation Drug Market Challenges
Table 142. Iron Chelation Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Iron Chelation Drug Product Picture
Figure 2. Global Iron Chelation Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Iron Chelation Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Transfusional Iron Overload Examples
Figure 7. NTDT Caused Iron Overload Examples
Figure 8. Global Iron Chelation Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Iron Chelation Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Iron Chelation Drug Sales (Kg) Growth Rate (2016-2027)
Figure 11. Global Iron Chelation Drug Price Trends Growth Rate (2016-2027) (USD/g)
Figure 12. Global Iron Chelation Drug Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Iron Chelation Drug Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Iron Chelation Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Iron Chelation Drug Sales (Kg) Growth Rate (2016-2027)
Figure 16. Europe Iron Chelation Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Iron Chelation Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Iron Chelation Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Iron Chelation Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Iron Chelation Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Iron Chelation Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Iron Chelation Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Iron Chelation Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Iron Chelation Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Iron Chelation Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Iron Chelation Drug Players Market Share by Revenue in Iron Chelation Drug: 2016 & 2020
Figure 27. Iron Chelation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Iron Chelation Drug Revenue Share by Type (2016-2021)
Figure 29. Global Iron Chelation Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Iron Chelation Drug Revenue Share by Application (2016-2021)
Figure 31. Global Iron Chelation Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Iron Chelation Drug Sales Market Share by Type in 2020
Figure 33. North America Iron Chelation Drug Sales Market Share by Application in 2020
Figure 34. Europe Iron Chelation Drug Sales Market Share by Type in 2020
Figure 35. Europe Iron Chelation Drug Sales Market Share by Application in 2020
Figure 36. China Iron Chelation Drug Sales Market Share by Type in 2020
Figure 37. China Iron Chelation Drug Sales Market Share by Application in 2020
Figure 38. Japan Iron Chelation Drug Sales Market Share by Type in 2020
Figure 39. Japan Iron Chelation Drug Sales Market Share by Application in 2020
Figure 40. Southeast Asia Iron Chelation Drug Sales Market Share by Type in 2020
Figure 41. Southeast Asia Iron Chelation Drug Sales Market Share by Application in 2020
Figure 42. India Iron Chelation Drug Sales Market Share by Type in 2020
Figure 43. India Iron Chelation Drug Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Iron Chelation Drug
Figure 46. Manufacturing Process Analysis of Iron Chelation Drug
Figure 47. Iron Chelation Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の鉄欠乏性貧血治療薬市場規模・現状・予測（2021年-2027年） Iron deficiency anemia is a decrease in the red cells of the blood caused by too little iron.The most economical and effective medical treatment for iron deficiency anemia is the oral administration of ferrous iron salts. Market Analysis and Insights: Global Iron Deficiency Anemia Drug Market The gl…- 世界の海綿鉄粉（SIP）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sponge Iron Powder (SIP) Market The global Sponge Iron Powder (SIP) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のIV＆経口鉄剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global IV and Oral Iron Drugs Market The global IV and Oral Iron Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の静脈内（IV）鉄投与療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Intravenous (IV) Iron Therapy Market The global Intravenous (IV) Iron Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- ホットブリケッティングアイアン(HBI)のグローバル市場2021 Hot Briquetted Iron (HBI) is a premium form of DRI that has been compacted at a temperature greater than 650° C at time of compaction and has a density greater than 5,000 kilograms per cubic metre (5,000 kg/m3). HBI was developed as a product in order to overcome the problems associated with shippin…